IDH2 and acute myeloid leukemia: In CN-AML with a favorable genotype (NPM or CEBPA mutated/FLT3 wt), IDH mutations were associated with poor outcome [60,63-65], thereby indicating a possibility of further refinement of this subgroup of CN-AML.